Nuria Esforzado

Nuria Esforzado

Auto-generated profile, based on publicly available information

Nuria Esforzado

Renal Transplant Unit, Nephrology and Renal Transplantation Department Hospital Clínic Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2021 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
CACarolt Arana Aliaga
Carolt Arana Aliaga
RRRafael E. Cuevas Ramírez
Rafael E. Cuevas Ramírez
MXMarc Xipell
Marc Xipell
JCJoaquim Casals
Joaquim Casals
ACAsunción Moreno Camacho
Asunción Moreno Camacho
NENúria Esforzado
Núria Esforzado

30 January 2012
Verified
Book Chapter
Closed access
PDF file
BDBeatriz Domínguez-Gil
Beatriz Domínguez-Gil
NENuria Esforzado
Nuria Esforzado
AAAmado Andrés
Amado Andrés
JCJosep M. Campistol
Josep M. Campistol
JMJose M. Morales
Jose M. Morales
Transplantation of kidneys from donors with a positive serology for hepatitis C virus (HCVD+) remains controversial as made evident by wide variations in practice. Current knowledge derived from unicenter and registry experiences have demonstrated that the use of HCVD+ kidneys in HCV+ recipients seems to be safe in the long-term. This information, summarized in this chapter, has provided the basis for internationally agreed recommendations which limit the use of these kidneys for transplantation in recipients with a positive HCV RNA while on the waiting list and consenting in advance. Avoiding superinfection might require matching donors and recipients based on the involved HCV genotype, an approach limited by obvious time constraints. Because the incidence and prevalence of HCV infection is decreasing and there is a proactive treatment of patients with end-stage renal disease and HCV infection before being included on the waiting list, kidneys from HCVD+ are becoming surplus organs due to the lack of appropriate recipients. The underutilization of these kidneys at a moment of dramatic organ shortage requires organizational measures, including the offer of these kidneys for preemptive transplantation, besides the need of reviewing the evidence driving local criteria.

21 August 2018 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
MBMarta Bodro
Marta Bodro
MLMaria Carlota Londono
Maria Carlota Londono
NENuria Esforzado
Nuria Esforzado
GSGemma Sanclemente
Gemma Sanclemente
LLLaura Linares
Laura Linares
ACAsunción Moreno Camacho
Asunción Moreno Camacho

1 November 2012 in Transplantation
Verified
Journal Article
Open access
BDB. Domínguez-Gil
B. Domínguez-Gil
CCC. Cortijo
C. Cortijo
NEN. Esforzado
N. Esforzado
AAA. Andrés
A. Andrés
FOF. Oppenheimer
F. Oppenheimer
JMJ. M. Morales
J. M. Morales

25 August 2025 in HIV Medicine
Verified
Journal Article
Closed access
JCJudit Cacho
Judit Cacho
DNDaniel K. Nomah
Daniel K. Nomah
NENatalia Egri
Natalia Egri
FCFrederic Cofán
Frederic Cofán
MMMaría Ángeles Marcos
María Ángeles Marcos
DCDavid Cucchiari
David Cucchiari

15 March 2019 in European Urology Supplements
Verified
Journal Article
Closed access
MMM. Musquera
M. Musquera
ASAlba Sierra
Alba Sierra
LPL. Peri
L. Peri
DPD. Paredes
D. Paredes
CBC. Mercader Barrull
C. Mercader Barrull
AAAntonio Alcaraz
Antonio Alcaraz